5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Pharmacometrics and Machine Learning Partner to Advance Clinical Data Analysis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Clinical pharmacology is a multidisciplinary data sciences field that utilizes mathematical and statistical methods to generate maximal knowledge from data. Pharmacometrics (PMX) is a well‐recognized tool to characterize disease progression, pharmacokinetics, and risk factors. Because the amount of data produced keeps growing with increasing pace, the computational effort necessary for PMX models is also increasing. Additionally, computationally efficient methods, such as machine learning (ML) are becoming increasingly important in medicine. However, ML is currently not an integrated part of PMX, for various reasons. The goals of this article are to (i) provide an introduction to ML classification methods, (ii) provide examples for a ML classification analysis to identify covariates based on specific research questions, (iii) examine a clinically relevant example to investigate possible relationships of ML and PMX, and (iv) present a summary of ML and PMX tasks to develop clinical decision support tools.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Exploiting machine learning for end-to-end drug discovery and development

          A variety of machine learning methods such as Naïve Bayesian, support vector machines and more recently deep neural networks are demonstrating their utility for drug discovery and development. These leverage the generally bigger data sets created from high throughput screening data and allow prediction of bioactivities for targets and molecular properties with increased levels of accuracy. We have only just begun to exploit the potential of these techniques but they may already be fundamentally changing the research process for identifying new molecules and/or repurposing old drugs. The integrated application of such machine learning models for end-to-end (E2E) application is broadly relevant and has considerable implications for developing future therapies and their targeting.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Data science and prediction

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              How to develop machine learning models for healthcare

                Bookmark

                Author and article information

                Contributors
                gilbert.koch@ukbb.ch
                julia.vogt@inf.ethz.ch
                Journal
                Clin Pharmacol Ther
                Clin. Pharmacol. Ther
                10.1002/(ISSN)1532-6535
                CPT
                Clinical Pharmacology and Therapeutics
                John Wiley and Sons Inc. (Hoboken )
                0009-9236
                1532-6535
                17 February 2020
                April 2020
                17 February 2020
                : 107
                : 4 , Data Science ( doiID: 10.1002/cpt.v107.4 )
                : 926-933
                Affiliations
                [ 1 ] Paediatric Pharmacology and Pharmacometrics Research University of Basel Children’s Hospital (UKBB) Basel Switzerland
                [ 2 ] Institute for Machine Learning Department of Computer Science ETH Zurich Zurich Switzerland
                [ 3 ] University Children's Hospital Regensburg (KUNO) University of Regensburg Regensburg Germany
                Author notes
                [*] [* ] Correspondence: Gilbert Koch ( gilbert.koch@ 123456ukbb.ch ) and Julia E. Vogt ( julia.vogt@ 123456inf.ethz.ch )

                Article
                CPT1774
                10.1002/cpt.1774
                7158220
                31930487
                485c04f5-f288-4a91-b2f3-d52f690bde95
                © 2020 The Authors. Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 17 October 2019
                : 12 December 2019
                Page count
                Figures: 3, Tables: 3, Pages: 8, Words: 6624
                Categories
                Article
                Research
                Articles
                Custom metadata
                2.0
                April 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.0 mode:remove_FC converted:14.04.2020

                Pharmacology & Pharmaceutical medicine
                Pharmacology & Pharmaceutical medicine

                Comments

                Comment on this article